blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1644743

EP1644743 - THYROID HORMONE ANALYSIS BY MASS SPECTROMETRY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.09.2015
Database last updated on 20.05.2024
Most recent event   Tooltip27.10.2017Lapse of the patent in a contracting state
New state(s): BE		published on 29.11.2017  [2017/48]
Applicant(s)For all designated states
GEORGETOWN UNIVERSITY
37th and O Streets, N.W.
Washington, DC 20057 / US
[2014/26]
Former [2006/15]For all designated states
GEORGETOWN UNIVERSITY
37th and O Street, N.W.
Washington, DC 20057-1408 / US
Inventor(s)01 / SOLDIN, Steven, J.
6308 Walhonding Road
Bethesda, Maryland 20816 / US
 [2006/15]
Representative(s)Roberts, Mark Peter
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[2014/46]
Former [2006/15]Roberts, Mark Peter
J.A. Kemp & Co., 14 South Square, Gray's Inn
London WC1R 5JJ / GB
Application number, filing date04727197.814.04.2004
[2006/15]
WO2004CA00555
Priority number, dateUS20030462745P14.04.2003         Original published format: US 462745 P
[2006/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004090553
Date:21.10.2004
Language:EN
[2004/43]
Type: A1 Application with search report 
No.:EP1644743
Date:12.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 21.10.2004 takes the place of the publication of the European patent application.
[2006/15]
Type: B1 Patent specification 
No.:EP1644743
Date:12.11.2014
Language:EN
[2014/46]
Search report(s)International search report - published on:EP21.10.2004
ClassificationIPC:G01N33/78
[2006/15]
CPC:
G01N33/6848 (EP,US); G01N33/78 (EP,US); Y10T436/24 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/15]
TitleGerman:BESTIMMUNG VON THYROIDHORMONEN MITTELS MASSENSPEKTROMETRIE[2006/15]
English:THYROID HORMONE ANALYSIS BY MASS SPECTROMETRY[2006/15]
French:ANALYSE D'HORMONES THYROIDIENNES PAR SPECTROMETRIE DE MASSE[2006/15]
Entry into regional phase10.10.2005National basic fee paid 
10.10.2005Designation fee(s) paid 
10.10.2005Examination fee paid 
Examination procedure10.10.2005Examination requested  [2006/15]
12.12.2008Despatch of a communication from the examining division (Time limit: M06)
17.06.2009Reply to a communication from the examining division
25.07.2011Despatch of a communication from the examining division (Time limit: M06)
26.01.2012Reply to a communication from the examining division
01.10.2012Despatch of a communication from the examining division (Time limit: M06)
13.03.2013Reply to a communication from the examining division
07.10.2013Despatch of a communication from the examining division (Time limit: M04)
11.02.2014Reply to a communication from the examining division
02.06.2014Communication of intention to grant the patent
02.10.2014Fee for grant paid
02.10.2014Fee for publishing/printing paid
02.10.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.12.2008
Opposition(s)13.08.2015No opposition filed within time limit [2015/43]
Fees paidRenewal fee
17.03.2006Renewal fee patent year 03
12.04.2007Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
16.04.2009Renewal fee patent year 06
25.03.2010Renewal fee patent year 07
12.04.2011Renewal fee patent year 08
25.04.2012Renewal fee patent year 09
29.04.2013Renewal fee patent year 10
28.04.2014Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.04.2004
AT12.11.2014
BE12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
TR12.11.2014
GR13.02.2015
PT12.03.2015
IE14.04.2015
LU14.04.2015
CH30.04.2015
LI30.04.2015
[2017/46]
Former [2017/39]HU14.04.2004
AT12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
TR12.11.2014
GR13.02.2015
PT12.03.2015
IE14.04.2015
LU14.04.2015
CH30.04.2015
LI30.04.2015
Former [2016/20]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
GR13.02.2015
PT12.03.2015
IE14.04.2015
LU14.04.2015
CH30.04.2015
LI30.04.2015
Former [2016/12]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
GR13.02.2015
PT12.03.2015
LU14.04.2015
CH30.04.2015
LI30.04.2015
Former [2016/06]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
PT12.03.2015
LU14.04.2015
CH30.04.2015
LI30.04.2015
Former [2016/03]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
PT12.03.2015
LU14.04.2015
Former [2016/01]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
PT12.03.2015
LU14.04.2015
Former [2015/52]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
PT12.03.2015
LU14.04.2015
Former [2015/37]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
PT12.03.2015
Former [2015/36]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
GR13.02.2015
PT12.03.2015
Former [2015/35]AT12.11.2014
CY12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
PT12.03.2015
Former [2015/34]AT12.11.2014
CY12.11.2014
DK12.11.2014
ES12.11.2014
FI12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
PT12.03.2015
Former [2015/26]AT12.11.2014
CY12.11.2014
ES12.11.2014
FI12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
PT12.03.2015
Former [2015/25]AT12.11.2014
ES12.11.2014
FI12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
PT12.03.2015
Former [2015/24]ES12.11.2014
FI12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
PT12.03.2015
Former [2015/23]ES12.11.2014
FI12.11.2014
NL12.11.2014
PT12.03.2015
Former [2015/22]PT12.03.2015
Cited inInternational search[A]WO0246772  (WOMENS & CHILDRENS HOSPITAL [AU], et al) [A] 1-63 * page 4 - page 9 *;
 [A]  - SIEKMANN L, "Measurement of thyroxine in human serum by isotope dilution mass spectrometry. Definitive methods in clinical chemistry, V", BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, (198711), vol. 14, no. 11, pages 683 - 688, XP009032600 [A] 1-63 * abstract * * page 685 *

DOI:   http://dx.doi.org/10.1002/bms.1200141120
 [AD]  - THIENPONT LM ET AL, "Development of a new method for the determination of thyroxine in serum based on isotope dilution gas chromatography mass spectrometry", BIOL MASS SPECTROM, (1994), vol. 23, no. 8, pages 475 - 482, XP009032585 [AD] 1-63 * abstract * * page 476 - page 477 *

DOI:   http://dx.doi.org/10.1002/bms.1200230804
 [XY]  - DE BRABANDERE VI ET AL, "Isotope dilution-liquid chromatography/electrospray ionization-tandem mass spectrometry for the determination of serum thyroxine as a potential reference method", RAPID COMMUN MASS SPECTROM, (1998), vol. 12, no. 16, pages 1099 - 1103, XP009032587 [X] 1-9,12-27,58-63 * abstract * * page 1100 - page 1101 * [Y] 1-63
 [X]  - KOSAKA TAEKO ET AL, "Analysis of thyroid hormones in health foods by LC/MS", SHOKUHIN EISEIGAKU ZASSHI, (200208), vol. 43, no. 4, pages 225 - 229, XP009032605 [X] 1-3,12,14,15,17-25,27,58-63 * abstract *
 [XY]  - TAI, SSC ET AL, "Candidate reference method for total thyroxine in human serum: use of isotope dilution liquid chromatography-mass spectrometry with electrospray ionization", CLINICAL CHEMISTRY, (2002), vol. 48, no. 4, pages 637 - 642, XP001182083 [X] 1-9,12-27,58-63 * abstract * * page 638 - page 639 * [Y] 1-63
 [Y]  - CHANG Y-C ET AL, "Quantitative measurement of male steroid hormones using automated on line solid phase extraction liquid chromatography tandem mass spectrometry and comparison with radioimmunoassay", ANALYST, UK, (20030401), vol. 128, no. 4, pages 363 - 368, XP009032863 [Y] 28-57 * the whole document *

DOI:   http://dx.doi.org/10.1039/b210111b
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.